This McCormick Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

Needham analyst Mike Matson upgraded the rating for Haemonetics Corporation HAE from Hold to Buy and announced a price target of $112. Haemonetics shares fell 2.8% to close at $83.41 on Tuesday. See how other analysts view this stock.
Morgan Stanley analyst Meta Marshall upgraded Ciena Corporation CIEN from Equal-Weight to Overweight, while raising the price target from $53 to $55. Ciena shares rose 0.2% to settle at $45.92 on Tuesday. See how other analysts view this stock.
Citigroup analyst Thomas Palmer upgraded McCormick & Company, Incorporated MKC from Sell to Neutral and increased the price target from $68 to $69. McCormick shares rose 1.6% to settle at $69.20 on Tuesday. See how other analysts view this stock. See how other analysts view this stock.
Barclays analyst Raimo Lenschow upgraded the rating for Klaviyo, Inc. KVYO from Equal-Weight to Overweight, while boosting the price target from $25 to $29. Klaviyo shares rose 0.1% to close at $22.58 on Tuesday. See how other analysts view this stock.
Citigroup analyst Thomas Palmer upgraded Darling Ingredients Inc. DAR from Neutral to Buy and announced a price target of $48. Darling Ingredients shares fell 1.5% to settle at $37.34 on Tuesday. See how other analysts view this stock.